Future Diagnostics Solutions is the obvious choice for in vitro diagnostic (IVD) assay developments – for start-ups, mid-sized biotech companies and multinationals in the global IVD medical device market.
Apart from developing complete IVD immunoassays, we also offer flexible support developments for ELISA, Point-of-Care, Microfluidics, Multiplex, Micro-Arrays, Performance Evaluations and Verification & Validation. Our enthusiastic and skilled experts will help your R&D team accelerate and bring your immunoassay to market successfully.
Whether you need highly specialized knowledge or manpower to bring your concept to market, Future Diagnostics is your trusted independent partner for any type of immuno assay development using any type of technology on any type of analyser.
To ensure highest quality, conformity and transparency, Future Diagnostics applies their proven New Product Development Process to all assay developments. Naturally, EN 13612:2002 and EN ISO 23640:2015 requirements and applicable CLSI guidelines are incorporated in this process, as is writing part of the technical file you need for IVD registration. Throughout the project, the dedicated expert team will involve you on a regular basis, and you can also monitor progress real-time – in SharePoint.